NATCO Pharma Limited – NSE:NATCOPHARM.NS

NATCO Pharma Limited stock price today

INR 921.05
-470.95
-33.83%
Financial Health
0
1
2
3
4
5
6
7
8
9

NATCO Pharma Limited stock price monthly change

+17.53%
month

NATCO Pharma Limited stock price quarterly change

+17.53%
quarter

NATCO Pharma Limited stock price yearly change

+73.62%
year

NATCO Pharma Limited key metrics

Market Cap
 248.70B
Enterprise value
 250.35B
P/E
 12.82
EV/Sales
 5.48
EV/EBITDA
 9.75
Price/Sales
 5.46
Price/Book
 3.48
PEG ratio
 1.99
EPS
 77.31
Revenue
 39.98B
EBITDA
 18.37B
Income
 13.88B
Revenue Q/Q
 N/A
Revenue Y/Y
 N/A
Profit margin
 42.64%
Oper. margin
 48.72%
Gross margin
 77.05%
EBIT margin
 48.72%
EBITDA margin
 45.95%

Get more financial ratios!

  • Every financial ratio you might need

  • 10 years history

  • Forward ratios (Analysts estimates)

Sign up &
create your own Smart Feed

Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.

Sign up for free

NATCO Pharma Limited stock price history

NATCO Pharma Limited stock forecast

NATCO Pharma Limited financial statements

Profit Margin

NATCO Pharma Limited (NSE:NATCOPHARM.NS): Profit margin
Jun 2023 11.40B 4.20B 36.85%
Sep 2023 10.31B 3.69B 35.78%
Dec 2023 7.58B 2.12B 28.04%
Mar 2024 10.68B 3.86B 36.16%
NATCOPHARM.NS income statement history

NATCO Pharma Limited Financials Estimate

NATCO Pharma Limited (NSE:NATCOPHARM.NS): Analyst Estimates
2026 53.27B 18.22B 34.21%
2027 34.14B 6.47B 18.97%

  • Analysts Price target

  • Financials & Ratios estimates

Show more
0.41%
Yield TTM
NATCO Pharma Limited (NSE:NATCOPHARM.NS): Payout ratio
Payout ratio 0%
NATCO Pharma Limited (NSE:NATCOPHARM.NS): Dividend Yield
2016 0.37%
2017 0.95%
2019 1.06%
2020 1.67%
2022 0.6%
NATCOPHARM.NS dividends history

Debt to Assets

NATCO Pharma Limited (NSE:NATCOPHARM.NS): Debt to assets
Dec 2022 0 0
Sep 2023 62540000000 9.60B 15.36%
Dec 2023 0 0
Mar 2024 69063000000 10.53B 15.25%
NATCOPHARM.NS balance sheet history

Cash Flow

NATCO Pharma Limited (NSE:NATCOPHARM.NS): Cash Flow
Mar 2023 820M 0 0
Jun 2023 870M 0 0
Sep 2023 872M 0 0
Dec 2023 884M 0 0
NATCOPHARM.NS cash flow history

NATCO Pharma Limited alternative data

NATCO Pharma Limited
Employees

NATCO Pharma Limited (NSE:NATCOPHARM.NS): Employee count
Aug 2023 4,025
Sep 2023 4,025
Oct 2023 3,946
Nov 2023 3,946
Dec 2023 3,946
Jan 2024 3,946
Feb 2024 3,946
Apr 2024 3,946
May 2024 3,946
Jun 2024 3,946
Jul 2024 3,946

NATCO Pharma Limited other data

Frequently Asked Questions (FAQ)

  • What's the price of NATCO Pharma Limited stock today?

    One share of NATCO Pharma Limited stock can currently be purchased for approximately $921.05.

  • When is NATCO Pharma Limited's next earnings date?

    Unfortunately, NATCO Pharma Limited's (NATCOPHARM.NS) next earnings date is currently unknown.

  • Does NATCO Pharma Limited pay dividends?

    Yes, NATCO Pharma Limited pays dividends and its trailing 12-month yield is 0.41% with 0% payout ratio. The last NATCO Pharma Limited stock dividend of $0 was paid on 11 Sep 2025.

  • How much money does NATCO Pharma Limited make?

    NATCO Pharma Limited has a market capitalization of 248.70B and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 110.09% to 40.02B US dollars.

  • What is NATCO Pharma Limited's stock symbol?

    NATCO Pharma Limited is traded on the NSE under the ticker symbol "NATCOPHARM.NS".

  • What is NATCO Pharma Limited's primary industry?

    Company operates in the Healthcare sector and Drug Manufacturers - Specialty & Generic industry.

  • How do i buy shares of NATCO Pharma Limited?

    Shares of NATCO Pharma Limited can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

  • How many employees does NATCO Pharma Limited have?

    As Jul 2024, NATCO Pharma Limited employs 3,946 workers.

  • When NATCO Pharma Limited went public?

    NATCO Pharma Limited is publicly traded company for more then 29 years since IPO on 1 Jan 1996.

  • What is NATCO Pharma Limited's official website?

    The official website for NATCO Pharma Limited is natcopharma.co.in.

  • How can i contact NATCO Pharma Limited?

    NATCO Pharma Limited can be reached via phone at +91 40 2354 7532.

NATCO Pharma Limited company profile:

NATCO Pharma Limited

natcopharma.co.in
Exchange:

NSE

Full time employees:

4,016

Industry:

Drug Manufacturers - Specialty & Generic

Sector:

Healthcare

NATCO Pharma Limited, a pharmaceutical company, develops, manufactures, and markets finished dosage formulations and active pharmaceutical ingredients (APIs). It offers formulations in various therapeutic areas, including cancers of blood, liver, kidney, lung, brain, breast, ovary, etc.; and APIs in various categories, such as oncology, central nervous system, pain management, and CV care. The company also offers orthopedic products comprising bisphosphonates, which are oral and injectable drugs; and gastroenterology products consisting of novel drugs for chronic hepatitis-B and hepatitis-C, as well as contract manufacturing services. In addition, it provides cardiology and diabetology products for the treatment of hypertension, stable angina and CHF. The company markets its products in approximately 40 countries, including India, the United States, and internationally. NATCO Pharma Limited was incorporated in 1981 and is headquartered in Hyderabad, India.

+91 40 2354 7532
NATCO House
Hyderabad, 500034

:
ISIN: INE987B01026
CUSIP: Y6211C157